Free Trial

ABVC BioPharma (ABVC) Institutional Ownership

ABVC BioPharma logo
$0.52 +0.01 (+1.22%)
(As of 12/20/2024 05:31 PM ET)

Institutional Ownership Changes (13F Filings) for ABVC BioPharma (NASDAQ:ABVC)

Current
Institutional Ownership
Percentage
11.38%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$233.67K
Number of
Institutional Sellers
(last 12 months)
0
Get ABVC Insider Trade Alerts

Want to know when executives and insiders are buying or selling ABVC BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ABVC BioPharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/2/2024 Chase Investment Counsel Corp178,377$233K0.1%N/A1.689%
11/16/2021 Squarepoint Ops LLC19,207$44K0.0%N/A0.072%
11/12/2021Credit Suisse AG11,709$27K0.0%N/A0.044%
(Data available from 1/1/2016 forward)

ABVC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABVC shares?

During the previous two years, the following institutional investors and hedge funds held shares of ABVC BioPharma shares: Chase Investment Counsel Corp ($233K).Learn more on ABVC's institutional investors.

What percentage of ABVC BioPharma stock is owned by institutional investors?

11.38% of ABVC BioPharma stock is owned by institutional investors. Learn more on ABVC's institutional investor holdings.

Which institutional investors have been buying ABVC BioPharma stock?

The following institutional investors have purchased ABVC BioPharma stock in the last 24 months: Chase Investment Counsel Corp ($178.38K).

How much institutional buying is happening at ABVC BioPharma?

Institutional investors have bought a total of 178,377 shares in the last 24 months. This purchase volume represents approximately $233.67K in transactions.



This page (NASDAQ:ABVC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners